Improving access to the National Suicide Prevention Lifeline for people with alcohol use disorders
Facilitating use of the National Suicide Prevention Lifeline in Alcohol Patients
This study is looking to improve the National Suicide Prevention Lifeline for people with Alcohol Use Disorders who may be at risk of suicide, by finding better ways to encourage them to reach out for help when they need it most.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10659125 on NIH RePORTER |
What this research studies
This research focuses on individuals with Alcohol Use Disorders (AUDs) who are at a heightened risk for suicide. It aims to enhance the effectiveness of the National Suicide Prevention Lifeline by tailoring its services to better meet the needs of those struggling with AUDs. The study will explore how to increase the utilization of this lifeline among patients, particularly during moments of crisis when they are most vulnerable. By analyzing the patterns of calls and outcomes, the research seeks to identify strategies that could potentially lower the risk of suicide in this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing alcohol use disorders and may be at risk for suicidal behavior.
Not a fit: Patients who do not have alcohol use disorders or are not at risk for suicide may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in suicide attempts and fatalities among individuals with alcohol use disorders.
How similar studies have performed: While the National Suicide Prevention Lifeline has been widely used, this specific approach to enhancing its effectiveness for individuals with AUDs is novel and has not been extensively tested.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Ilgen, Mark a. — University of Michigan at Ann Arbor
- Study coordinator: Ilgen, Mark a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.